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Abstract LIM-kinase 1 (LIMKl) and 2 (LIMK2) are members 
of a novel class of protein kinases containing two LIM motifs at 
the N-terminus. The LIM motif is thought to be involved in 
protein-protein interactions. We report here evidence that 
LIMKl self-associates and also associates with LIMKZ. In vivo 
and in vitro binding analyses using variously deleted mutants of 
LIMKl revealed that the self-association of LIMKl was caused 
by interaction between the N-terminal LIM domain and the C- 
terminal kinase domain. The association of LIMKl with itself 
and with LIMKZ is important for understanding how activities 
and functions of LIMK family kinases are regulated. 
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1. Introduction 
Protein kinases play a central role in intracellular signal- 
transducing pathways which regulate cell growth, differentia- 
tion and other responses. We recently identified a novel class 
of protein kinases, termed LIM kinases (LIMKs), composed 
of LIMKl and LIMK2 [l&4]. These two kinases share char- 
acteristic structural features, consisting of the N-terminal two 
LIM motifs, the internal PDZ (also called DHR or GLGF)- 
like domain, and the C-terminal protein kinase domain. The 
LIM motif is a structural motif composed of two adjacent 
zinc fingers separated by a 2-amino acid linker [5,6]. The 
PDZ domain is a 90-100 amino acid motif found in a diverse 
set of membrane-bound proteins and enzymes [7,8]. Both of 
these domains were characterized as the binding surfaces of 
protein-protein interactions [5-S], and may be involved in 
regulation of the kinase activity or in the subcellular localiza- 
tion of LIMKs. The C-terminal kinase domains of LIMKs 
contain a consensus sequence of protein kinases, but are 
unique in that they have an unusual sequence motif 
(DLNSHN) in the kinase catalytic loop in subdomain VIB 
and a highly basic kinase insert between subdomains VII 
and VIII [l+l]. The unique structural features of these kinases 
suggest their specific roles in previously uncharacterized sig- 
naling pathways. LIMKl is highly expressed in the brain in 
developing and adult mammals [14,9-111. The LIMKl gene 
is located on human chromosome 7q11.23 [3], and a recent 
report suggests that it is a gene linked to the impairment of 
visuospatial cognition in patients of Williams syndrome [12]. 
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The cellular functions and mechanisms of regulation of LIMK 
family kinases remain unknown. 
Several protein kinases form a homotypic dimer or oligo- 
mer to regulate their activity [13-161. As the LIM and PDZ 
domains are thought to be involved in protein-protein inter- 
actions, and in some cases in homophilic interactions [17,18], 
we asked whether LIMKs would self-associate through these 
domains. We now provide evidence that LIMKl self-associ- 
ates and also associates with LIMK2. We also show that the 
self-association of LIMKl is mediated by interactions be- 
tween the N-terminal LIM domain and the C-terminal protein 
kinase domain. 
2. Materials and methods 
2.1. Plasmid construction 
LIMKl mutants used in this study are schematically shown in Fig. 
1. pUC-SR~L expression plasmids encoding LIMKl-HA and LIMK2- 
HA were constructed to contain the epitope peptide (YPYDVPDYA) 
of influenza virus haemagglutinin (HA) at the C-terminus of human 
LIMKl (l-640) and LIMKZ (l-629), respectively. The full-length 
coding sequence of human LIMKl cDNA was inserted into pBlue- 
script (Stratagene), using a Not1 linker (PBS-LIMKl). To generate the 
plasmid encoding LIMKl-HA, the cDNA fragment was amplified by 
polymerase chain reaction (PCR), using the upper primer 5’-GA- 
CAGCCAGTACCCA-3’ and the lower primer S’-GCTCTAGAGG- 
CCTCAGGCCATAGTCGGGGACGTCATAGGGGGGTAAGGC- 
AGTCCGCTCTCGCC-3’ (containing an HA epitope, a stop codon 
and XbaI site). The PCR-amplified fragment was digested with SphI 
and XbaI and ligated into the SphI, XbaI-digested PBS-LIMKl, to 
replace the original SphI-XbaI fragment of LIMKl cDNA with the 
HA-tagged fragment. The resulting plasmid was cut with NotI, and 
the insert was subcloned into the pUC-SRCX vector [19] to produce 
pUC-SRWLIMKI-HA. To construct the expression plasmid pUC- 
SRa-ALIM-HA, pUC-SRc(-LIMKl-HA was digested with Ban and 
BstEII and ligated with a Hind111 linker. To construct the expression 
plasmid pUC-SRa-AInt-HA, pUC-SR&LIMKl-HA was digested 
with BstEII and PstI and ligated. To construct the plasmid pUC- 
SRa-AK-HA, pUC-SR&LIMKl-HA was digested with PstI and 
SphI and the PstI-SphI fragment within the LIMKl sequence was 
removed. The plasmid coding for glutathione S-transferase (GST)- 
fused LIMKl was constructed by inserting Hi&I-digested LIMKl 
cDNA into the SmaI site of pGEX-2T (Pharmacia). The plasmid 
coding for GST-fused LIMKl (6216) (GST-N) was generated by 
self-ligation of the EcoRI-digested pGEX-LIMKl. The plasmid cod- 
ing for GST-LIM was generated by digestion of pGEX-LIMKl with 
BstEII and SphI and ligation with an EcoRI linker. The authenticity 
of the expression plasmids was confirmed by nucleotide sequence 
analysis. 
2.2. Cell culture and transfection 
COS-7 cells were maintained in Dulbecco’s modified Eagle’s medi- 
um supplemented with 10% fetal calf serum. Cells were transfected 
with the plasmid DNA using the DEAE-dextran-chloroquine method, 
as described [3]. 
2.3. Immunoprecipitation and immunoblotting 
2 days after transfection, the cells were lysed with lysis buffer con- 
taining 50 mM Tris-HCl (pH 7.6), 150 mM NaCl, 10 mM NaF, 1 mM 
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NasVOd, 50 nM ZnClz, 1 mM dithiothreitol (DTT), 10% glycerol, 1% 
Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride (PMSF), 2 @ml 
antipain and’ 2 @ml leupeptin. After centrifugation, lysates were 
precleared with Protein A-Sepharose (Pharmacia) for 1 h at 4°C. 
The precleared supernatants were incubated with rabbit anti-LIMKl 
polyclonal antibody (LKl-C) [3] and Protein A-Sepharose for 2 h at 
4°C. After centrifugation, the immunoprecipitates were washed three 
times with washing buffer (50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 
10 mM NaF, 1 mM NasVOd, 50 uM ZnCla, 1 mM DTT and 0.5% 
Nonidet P-40) and used for immunoblot analysis. Immunoblot anal- 
ysis was performed as described [3], except that rabbit anti-HA poly- 
clonal antibody (HA.1 1, Babco) was used as the primary antibody in 
some experiments. 
(641-647)) were deleted from the LIMKl-HA construct. As 
shown in Fig. 2, anti-LIMKl antibody raised against the C- 
terminal peptide of human LIMKl immunoprecipitated and 
detected non-tagged LIMKl protein expressed in COS cells, 
but not HA-tagged LIMKl (l-640). Conversely, anti-HA 
antibody immuno-precipitated and detected HA-tagged 
LIMKl (l-640) but not non-tagged LIMKl. Thus, anti- 
LIMKl and anti-HA antibodies specifically recognized the 
epitopes at the C-termini of intact and HA-tagged LIMKl, 
respectively, and cross-reactivity was not observed. 
2.4. In vitro binding assay 
The plasmids coding for GST fusion proteins were transformed into 
Escherichia coli XLl-blue. Expression of GST fusion proteins was 
induced by 1 mM isopropyl thiogalactopyranoside (IPTG). Bacteria 
were collected 90 min.after the 
_. 
addition of IPTG and suspended in 
lvsis buffer containing 50 mM Tris-HCl (oH 7.6). 50 mM NaCl. 10 
mM NaF, 1 mM NasV04, 50 uM ZnClz, 1 mM DTT, 1% Triton X- 
100, 0.1% sodium deoxycholate, 1 mM PMSF, 2 @ml antipain and 
2 @ml leupeptin. After standing on ice for 15 min, suspensions were 
sonicated and cleared by centrifugation at 12000Xg for 20 min. The 
supernatants were added to glutathione-Sepharose (Pharmacia) and 
incubated for 2 h at 4°C. The beads were washed three times with 
washing buffer and used for in vitro binding assay. The lysates of 
COS cells expressing HA-tagged LIMKl mutants were precleared 
with glutathione-Sepharose and incubated for 1 h at 4°C with GST 
fusion proteins immobilized on glutathione-Sepharose, prepared as 
above. Beads were washed three times with washing buffer and the 
bound proteins were solubilized in SDS sample buffer at 95°C for 10 
min, run on SDS-PAGE and analyzed by western blotting with anti- 
HA antibody. 
3. Results 
3.1. Association of LIMKI with itself and with LIMK? 
To examine the self-association of LIMKl, we constructed 
two expression plasmids, one coding for non-tagged, full- 
length LIMKl (l-647) and the other coding for C-terminally 
HA-tagged LIMKl (I-640) (termed LIMKl-HA) (see Fig. 1). 
To avoid the cross-reaction with anti-LIMKl antibody, the 
C-terminal 7 amino acid residues (corresponding to LIMKl 
When LIMKl and LIMKI-HA were co-expressed in COS 
cells and LIMKl was immunoprecipitated with anti-LIMKl 
antibody, LIMKl-HA co-precipitated with LIMKl, which 
was detected by immunoblot analysis with anti-HA antibody 
(Fig. 3A, upper panel, lane 3). Co-precipitation of LIMK2- 
HA with LIMKl was also observed in a similar experiment 
(Fig. 3A, upper panel, lane 4). Expression of LIMKl, 
LIMKl-HA or LIMK2-HA in each experiment was con- 
firmed by immunoblot analyses (Fig. 3A, middle and lower 
panels). Together these findings suggest that LIMKl self-as- 
sociates to form a dimer or a multimer in the cell and that it 
can also associate with LIMK2 to form a heterotypic com- 
plex. Based on the amounts of LIMKl-HA and LIMK2-HA 
in the cell lysates, as estimated by direct immunoblot analysis 
with anti-HA antibody, about 1.6% of LIMKI-HA and about 
3.7% of LIMKZHA expressed in COS cells co-precipitated 
with LIMKl. 
3.2. Localization of the domains of LIMKI required for 
self-association 
To localize the domains of LIMKl required for self-asso- 
ciation, we constructed expression plasmids encoding non- 
tagged or HA-tagged version of AK, a LIMKl mutant with 
a deletion of the C-terminal kinase domain (amino acid resi- 
dues 297-610) (see Fig. 1). The non-tagged and HA-tagged 
versions of the full-size LIMKl or AK were mutually. co- 
transfected into COS cells, and the cell lysates were analyzed 
by immunoprecipitation with anti-LIMKl antibody, followed 
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Fig. 1. Diagram showing structures of human LIMKl and various mutants used in the present study. The hatched boxes represent LIM do- 
mains; black boxes, PDZ (DHR) domains; gray boxes, protein kinase domains; and horizontally striped boxes, HA-tag peptides. The deleted 
residues in each mutant are indicated in parentheses. 
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Fig. 2. Specificity of anti-LIMKl and anti-HA antibodies. COS-7 cells were transfected with the pUC-SRa expression vector (lane 1) or the 
vector encoding either LIMKl (lane 2) or LIMKl-HA (lane 3). Cell lysates were immunoprecipitated with anti-LIMKl (IX-LKl) or anti-HA 
epitope (a-HA) antibody, run on SDS-PAGE and immunoblotted with the same antibodies, as indicated. Arrows indicate the predicted posi- 
tions of LIMKl, LIMKl-HA and immunoglobulin heavy chain (IgH). The positions of molecular weight marker proteins are indicated on the 
left. IP, immunoprecipitation. 
by immunoblotting with anti-HA antibody. As shown in Fig. 
3B (top panel), LIMKl-HA co-precipitated with LIMKl and 
AK, and AK-HA co-precipitated with LIMKl. On the other 
hand, co-precipitation of AK-HA with AK was never evident. 
These observations suggest that the N-terminal half of 
LIMKl is involved in the self-association of LIMKl, but 
this association is not mediated by homotypic interactions 
between the N-terminal halves of LIMKl molecules, rather 
A 
IP:a-LKl 87- , 
blot : a-LKl 
P: - 87 - 
k=c 
LmKl-HA 
blot : a-HA LIMK2-HA 
1 2 3 4 
Fig. 3. Self-association of LIMKl and association between LIMKl and LIMK2 in COS cells. (A) Co-immunoprecipitation of LIMKl-HA and 
LIMK2-HA with LIMKl. COS-7 cells were transfected with SRa vector alone (lane 1) or co-transfected with LIMKl+SRa vector (lane 2), 
LIMKl+LIMKl-HA (lane 3), or LIMKl+LIMK2-HA (lane 4). Cell lysates (0.3 ml each) were immunoprecipitated with anti-LIMKl antibody, 
run on SDS-PAGE and blotted with anti-HA antibody (upper panel) or anti-LIMKl antibody (middle panel). Initial cell lysates (10 pl) were 
also directly run on SDS-PAGE and immunoblotted with anti-HA antibody (lower panel). IgH indicates the position of immunoglobulin heavy 
chain. (B) Co-precipitation analyses of LIMKl and AK. COS-7 cells were co-transfected with LIMKl+LIMKl-HA (lane l), LIMKl+AK-HA 
(lane 2), AK+LIMKl-HA (lane 3), or AK+AK-HA (lane 4). The cell lysates were immunoprecipitated and immunoblotted, as in (A). The posi- 
tions of molecular weight marker proteins are indicated on the left. 
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Fig. 4. In vitro binding analyses to localize the domains required for LIMKl self-association. (A) Expression of GST fusion proteins. GST, 
GST-N and GST-LIM were expressed in E. coli, purified by glutathione-Sepharose and run on SDS-PAGE. Proteins were visualized with Coo- 
massie blue staining. (B) In vitro binding assay. Cell lysates of COS cells transfected with the indicated plasmids were run on SDS-PAGE and 
immunoblotted with anti-HA antibody (input). The HA-tagged LIMKl mutants expressed in COS cells were incubated with GST, GST-N or 
GST-LIM bound to glutathione-Sepharose. The bound materials were run on SDS-PAGE and analyzed by irmnunoblotting with anti-HA anti- 
body (GST, GST-N and GST-LIM). The positions of molecular weight marker proteins are indicated on the left. 
interactions occur between the N-terminal and C-terminal 
halves of LIMKl. 
To further localize regions required for LIMKl self-associa- 
tion, a series of HA-tagged LIMKl deletion mutants was 
expressed in COS cells and the potential to interact with the 
GST fusion protein of the N-terminal half (residues 4-215) of 
LIMKl (GST-N) was examined. The HA-tagged LIMKl mu- 
tants used are shown in Fig. 1; ALIM-HA, AInt-HA and AK- 
HA represent the HA-tagged LIMKl mutants lacking the 
LIM domain (amino acid residues 34144) the internal region 
containing PDZ-like domain (residues 145-296), and the ki- 
nase domain (residues 297-610) respectively. GST-N and 
GST were immobilized on glutathione-Sepharose and incu- 
bated with the HA-tagged LIMKl mutants, then the pellets 
were analyzed by immunoblotting with anti-HA antibody. As 
shown in Fig. 4B, GST-N bound the mutants lacking the LIM 
domain (ALIM-HA) and the internal PDZ-like domain (AInt- 
HA), but did not bind AK-HA. There was no binding of any 
of the HA-tagged LIMKl mutants to the control GST. We 
also detected binding of ALIM-HA with GST-LIM, a GST 
fusion protein of LIMKl with deletion of residues 145-610 
(Figs. 1 and 4B). Taken together, these results indicate that 
the N-terminal LIM domain interacts with the C-terminal 
kinase domain and the self-association of LIMKl can prob- 
ably be explained by this interaction. 
4. Discussion 
LIM domains are found in a variety of proteins, including 
transcription factors, cytoskeletal proteins, protein kinases 
and other signaling proteins [5,6]. Other studies provided evi- 
dence that the LIM domains are involved in protein-protein 
Fig. 5. A putative model for the self-association of LIMKI. LIMKl may exist in a monomer and in a dimer form, in which the N-terminal 
LIM domain associates with the C-terminal kinase domain intramolecularly and intermolecularly, respectively. 
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interactions. For example, cysteine-rich protein (CRP) associ- 
ates with itself and with zyxin, through LIM-LIM interactions 
[17,20]. The LIM domains of Enigma recognize the tyrosine- 
containing short sequence motifs in the insulin receptor and 
Ret receptor tyrosine kinase [21,22]. The LIM domains of 
LIM only protein-l and -2 (LMO-1 and LMO-2) interact 
with the basic helix-loop-helix domains of TALl, TAL2 and 
LYLl [23]. In the present study, we showed that the LIM 
domain of LIMKl probably interacts with the protein kinase 
domain. Thus, the LIM domains act as conserved protein- 
binding modules in various signaling systems. However, no 
apparent sequence similarity has been found within the targets 
for the LIM domains, suggesting that the individual LIM 
domains likely have diverse binding specificities. This is in 
contrast to the SH2 and SH3 domains, which also function 
as protein binding modules in various signaling pathways but 
do have narrow target specificities to short sequence motifs, 
the phosphotyrosine-containing and proline-rich motifs, re- 
spectively [24]. The mechanisms by which the LIM domains 
recognize such diverse targets will be elucidated by ongoing 
studies on refinement of target sequences and three-dimen- 
sional structure analyses of LIM-target complexes. 
As seen in Raf, Akt, double-strand RNA-dependent protein 
kinase (PKR) and receptor tyrosine kinases, dimerization or 
oligomerization of protein kinases leads to promotion of their 
kinase activity [13-161. However, it is not clear at present 
whether this is also the case for LIMKl, since the kinase 
activity of the monomer form and the multimer form of 
LIMKl must be separated and measured separately. 
The binding potential of the N-terminal LIM domain to the 
C-terminal kinase domain suggests that this interaction may 
also function intramolecularly, as illustrated in Fig. 5. In the 
cases of LIM-homeodomain proteins such as Met-3, 1~1-1 and 
Xlim-1, it was proposed that the LIM domain interacts with 
the homeodomain within the molecule and that this interac- 
tion inhibits the DNA binding activity of the homeodomain 
[5,25-271. This inhibitory effect is thought to be released by 
association of the LIM domain with other activator proteins 
[5]. In a similar manner, the intra- and intermolecular inter- 
actions between the LIM domain and the protein kinase do- 
main of LIMKl may negatively regulate its catalytic function, 
and LIMKl may be activated by intermolecular interactions 
of the LIM domain with other activator proteins. In order to 
clarify mechanisms of the kinase activity of LIMKl, the ki- 
nase activity of LIMKl mutants destroyed in the LIM do- 
main will have to be determined and the LIM-binding pro- 
teins will need to be identified. 
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